Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

Παρόμοια τεκμήρια

• Safety of CAR T-cell therapy in kidney transplant recipients
  ανά: Mamlouk, Omar, κ.ά.
  Έκδοση: (2021)
• The promise of CAR T-cell therapy in aggressive B-cell lymphoma
  ανά: Nair, Ranjit, κ.ά.
  Έκδοση: (2018)
• Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy
  ανά: Elizabeth J Shpall, κ.ά.
  Έκδοση: (2025-10-01)
• Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma
  ανά: Strati, Paolo, κ.ά.
  Έκδοση: (2020)
• Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma
  ανά: Strati, Paolo, κ.ά.
  Έκδοση: (2021)